Spotlight On ATTR-CM
Welcome to Spotlight On ATTR-CM, your go-to source for the latest research, diagnostic advancements, and therapeutic strategies in transthyretin amyloid cardiomyopathy (ATTR-CM). Join leading cardiologists and researchers as they share their insights on this intricate condition to enhance patient care and outcomes.
16-30 of 54
The Limits of Traditional AFib Prediction Models in ATTR-CA
Heart MattersThe Limits of Traditional AFib Prediction Models in ATTR-CA
Quality of Life Conversations in ATTR-CM Care
Heart MattersQuality of Life Conversations in ATTR-CM Care
Kevin S. Shah, MD
Supporting Patients With ATTR-CM: Preserving Function and Quality of Life
Heart MattersSupporting Patients With ATTR-CM: Preserving Function and Quality of Life
Joban Vaishnav, MD
Counseling Patients on Disease Progression in ATTR-CM
Heart MattersCounseling Patients on Disease Progression in ATTR-CM
Joban Vaishnav, MD
Rethinking Thromboembolic Risk in ATTR-CM Care
Heart MattersRethinking Thromboembolic Risk in ATTR-CM Care
Silencers and Stabilizers in ATTR-CM: Challenging Assumptions
Heart MattersSilencers and Stabilizers in ATTR-CM: Challenging Assumptions
- advertisement
Heart Failure Hospitalization and Mortality in Cardiac Amyloidosis
Heart MattersHeart Failure Hospitalization and Mortality in Cardiac Amyloidosis
Frederick Ruberg, MD
Disease-Modifying Advances in ATTR-CM Management
Heart MattersDisease-Modifying Advances in ATTR-CM Management
Integrating CMR and Genetics to Improve ATTR-CM Diagnosis
AudioAbstractsIntegrating CMR and Genetics to Improve ATTR-CM Diagnosis
Ryan Quigley
Redefining ATTR Treatment: Key Mechanisms and Emerging Data
Heart MattersRedefining ATTR Treatment: Key Mechanisms and Emerging Data
Ahmad Masri, MD, MS
Advances in ATTR-CM: Evolving Diagnostics and Therapeutics
Heart MattersAdvances in ATTR-CM: Evolving Diagnostics and Therapeutics
Kevin Alexander
- advertisement
Treating ATTR-CM Early: A Shift From Reactive to Strategic Care
Heart MattersTreating ATTR-CM Early: A Shift From Reactive to Strategic Care
Quan Bui, MD
Advancing Diagnosis of Transthyretin Cardiac Amyloidosis in Underserved Populations
Heart MattersAdvancing Diagnosis of Transthyretin Cardiac Amyloidosis in Underserved Populations
Exploring Tafamidis Survival Data in Elderly Patients with ATTR-CM
AudioAbstractsExploring Tafamidis Survival Data in Elderly Patients with ATTR-CM
Hallie Blevins, PhD